Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

6.66
Delayed Data
As of Jun 24
 -0.34 / -4.86%
Today’s Change
5.27
Today|||52-Week Range
62.15
-79.44%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close7.00
Today’s open6.62
Day’s range6.41 - 6.79
Volume1,936,138
Average volume (3 months)2,353,872
Market cap$228.2M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-70.71%
Earnings growth (this year)+4.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+45.64%
P/E ratioNM
Price/Sales29.63
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.26-4.42%
MNOVMediciNova Inc-0.11-1.55%
CNCEConcert Pharmaceutic...-0.63-5.57%
--China Health Group I...-0.02-7.14%
Data as of 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$1.26
Annual revenue (last year)$36.8M
Annual profit (last year)-$170.4M
Net profit margin-463.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

Partner Offers

Search for Jobs